Literature DB >> 25866900

Amniocentesis for threatened preterm labor with intact membranes and the impact on adverse outcome in infants born at 22 to 28 weeks of gestation.

Yohei Maki1, Seishi Furukawa2, Yuki Kodama3, Hiroshi Sameshima4, Tsuyomu Ikenoue5.   

Abstract

BACKGROUND: It remains unclear whether performing amniocentesis to detect intra-amniotic infection is useful for improving neonatal outcomes. AIMS: To determine the efficacy of amniocentesis on the neonatal outcomes in women exhibiting threatened preterm labor and intact membranes. STUDY
DESIGN: Retrospective cohort study
SUBJECTS: A total of 174 women with threatened preterm labor and intact membranes at 22 to 33 weeks of gestation. Women with obvious clinical chorioamnionitis, multifetal pregnancy and/or major anomalies were excluded. OUTCOME MEASURES: Neonatal short- and long-term outcomes
RESULTS: Sixty-seven women underwent amniocentesis (Tap group), while the remaining 107 did not. The prevalence of a positive Gram stain or a positive culture result was 10% in the Tap group. The overall outcomes were not statistically different between the two groups, with the exception of borderline significance (p=0.052) in long-term outcomes, favoring the Tap group. We performed a subgroup analysis focusing on infants born at 22-28 weeks of gestation. Consequently, the Tap group had better neonatal outcomes than the no-Tap group with respect to both short-term (OR 0.19, 95%CI 0.07-0.55) and long-term (OR 0.15, 0.05-0.46) outcomes. A multivariate analysis revealed that after adjusting confounding factors, the gestational age at delivery (OR 0.4, 0.3-0.7) and amniocentesis (OR 0.1, 0.02-0.3) remained significantly different.
CONCLUSIONS: Amniocentesis is useful for improving neonatal outcomes in infants born at 22-28 weeks of gestation to women exhibiting preterm labor and intact membranes.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Amniocentesis; Chorioamnionitis; Intact membrane; Intra-amniotic infection; Long-term; Outcome; Preterm labor

Mesh:

Year:  2015        PMID: 25866900     DOI: 10.1016/j.earlhumdev.2015.03.006

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  5 in total

1.  Amniotic fluid rapid biomarkers are associated with intra-amniotic infection in preterm pregnancies regardless of the membrane status.

Authors:  T Myntti; L Rahkonen; M Tikkanen; A Pätäri-Sampo; J Paavonen; V Stefanovic
Journal:  J Perinatol       Date:  2016-04-07       Impact factor: 2.521

2.  Comparison of amniotic fluid matrix metalloproteinase-8 and cathelicidin in the diagnosis of intra-amniotic infection.

Authors:  T Myntti; L Rahkonen; A Pätäri-Sampo; M Tikkanen; T Sorsa; J Juhila; O Helve; S Andersson; J Paavonen; V Stefanovic
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

3.  A value of soluble Toll-like receptor 2 and 4 in vaginally obtained amniotic fluid for the prediction of histological chorioamnionitis.

Authors:  Greta Balciuniene; Violeta Gulbiniene; Greta Kvederaite-Budre; Irena Dumalakiene; Rita Viliene; Ingrida Pilypiene; Grazina S Drasutiene; Diana Ramasauskaite
Journal:  Acta Obstet Gynecol Scand       Date:  2021-07-26       Impact factor: 4.544

4.  Amniotic Fluid Infection in Preterm Pregnancies with Intact Membranes.

Authors:  Tarja Myntti; Leena Rahkonen; Irmeli Nupponen; Anu Pätäri-Sampo; Minna Tikkanen; Timo Sorsa; Juuso Juhila; Sture Andersson; Jorma Paavonen; Vedran Stefanovic
Journal:  Dis Markers       Date:  2017-01-12       Impact factor: 3.434

Review 5.  Candida Chorioamnionitis Leads to Preterm Birth and Adverse Fetal-Neonatal Outcome.

Authors:  Yohei Maki; Midori Fujisaki; Yuichiro Sato; Hiroshi Sameshima
Journal:  Infect Dis Obstet Gynecol       Date:  2017-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.